257 related articles for article (PubMed ID: 7704843)
1. Molecular characterization of a lipid-modified virulence-associated protein of Rhodococcus equi and its potential in protective immunity.
Tan C; Prescott JF; Patterson MC; Nicholson VM
Can J Vet Res; 1995 Jan; 59(1):51-9. PubMed ID: 7704843
[TBL] [Abstract][Full Text] [Related]
2. Assessment in mice of vapA-DNA vaccination against Rhodococcus equi infection.
Haghighi HR; Prescott JF
Vet Immunol Immunopathol; 2005 Apr; 104(3-4):215-25. PubMed ID: 15734542
[TBL] [Abstract][Full Text] [Related]
3. Foal IgG and opsonizing anti-Rhodococcus equi antibodies after immunization of pregnant mares with a protective VapA candidate vaccine.
Cauchard J; Sevin C; Ballet JJ; Taouji S
Vet Microbiol; 2004 Nov; 104(1-2):73-81. PubMed ID: 15530741
[TBL] [Abstract][Full Text] [Related]
4. Immunogenecity of synthetic peptides representing linear B-cell epitopes of VapA of Rhodococcus equi.
Taouji S; Nomura I; Giguère S; Tomomitsu S; Kakuda T; Ganne V; Takaï S
Vaccine; 2004 Mar; 22(9-10):1114-23. PubMed ID: 15003638
[TBL] [Abstract][Full Text] [Related]
5. Chimeric vapA/groEL2 DNA vaccines enhance clearance of Rhodococcus equi in aerosol challenged C3H/He mice.
Phumoonna T; Barton MD; Vanniasinkam T; Heuzenroeder MW
Vaccine; 2008 May; 26(20):2457-65. PubMed ID: 18423949
[TBL] [Abstract][Full Text] [Related]
6. Assessment of the immunogenic potential of Rhodococcus equi virulence associated protein (VapA) in mice.
Prescott JF; Patterson MC; Nicholson VM; Morein B; Yager JA
Vet Microbiol; 1997 Jun; 56(3-4):213-25. PubMed ID: 9226836
[TBL] [Abstract][Full Text] [Related]
7. Development of a live, attenuated, potential vaccine strain of R. equi expressing vapA and the virR operon, and virulence assessment in the mouse.
Whitehead AE; Parreira VR; Hewson J; Watson JL; Prescott JF
Vet Immunol Immunopathol; 2012 Jan; 145(1-2):479-84. PubMed ID: 22088674
[TBL] [Abstract][Full Text] [Related]
8. The effect of mutation on Rhodococcus equi virulence plasmid gene expression and mouse virulence.
Ren J; Prescott JF
Vet Microbiol; 2004 Nov; 103(3-4):219-30. PubMed ID: 15504593
[TBL] [Abstract][Full Text] [Related]
9. Use of Rhodococcus equi virulence-associated protein for immunization of foals against R equi pneumonia.
Prescott JF; Nicholson VM; Patterson MC; Zandona Meleiro MC; Caterino de Araujo A; Yager JA; Holmes MA
Am J Vet Res; 1997 Apr; 58(4):356-9. PubMed ID: 9099378
[TBL] [Abstract][Full Text] [Related]
10. Development of a Rhodococcus equi-Escherichia coli plasmid shuttle vector.
Zheng H; Tkachuk-Saad O; Prescott JF
Plasmid; 1997; 38(3):180-7. PubMed ID: 9435020
[TBL] [Abstract][Full Text] [Related]
11. Mucosal co-immunization of mice with recombinant lactococci secreting VapA antigen and leptin elicits a protective immune response against Rhodococcus equi infection.
Cauchard S; Bermúdez-Humarán LG; Blugeon S; Laugier C; Langella P; Cauchard J
Vaccine; 2011 Dec; 30(1):95-102. PubMed ID: 22019740
[TBL] [Abstract][Full Text] [Related]
12. B-Cell epitope mapping of the VapA protein of Rhodococcus equi: implications for early detection of R. equi disease in foals.
Vanniasinkam T; Barton MD; Heuzenroeder MW
J Clin Microbiol; 2001 Apr; 39(4):1633-7. PubMed ID: 11283104
[TBL] [Abstract][Full Text] [Related]
13. Recognition of a B-cell epitope of the VapA protein of Rhodococcus equi in newborn and experimentally infected foals.
Phumoonna T; Barton MD; Heuzenroeder MW
J Vet Med B Infect Dis Vet Public Health; 2005 Aug; 52(6):291-5. PubMed ID: 16219093
[TBL] [Abstract][Full Text] [Related]
14. Clinical evaluation of a peptide-ELISA based upon N-terminal B-cell epitope of the VapA protein for diagnosis of Rhodococcus equi pneumonia in foals.
Phumoonna T; Muscatello G; Chicken C; Gilkerson JR; Browning GF; Barton MD; Heuzenroeder MW
J Vet Med B Infect Dis Vet Public Health; 2006 Apr; 53(3):126-32. PubMed ID: 16629724
[TBL] [Abstract][Full Text] [Related]
15. The LysR-type transcriptional regulator VirR is required for expression of the virulence gene vapA of Rhodococcus equi ATCC 33701.
Russell DA; Byrne GA; O'Connell EP; Boland CA; Meijer WG
J Bacteriol; 2004 Sep; 186(17):5576-84. PubMed ID: 15317761
[TBL] [Abstract][Full Text] [Related]
16. Immune response to vaccines based upon the VapA protein of the horse pathogen, Rhodococcus equi, in a murine model.
Vanniasinkam T; Barton MD; Heuzenroeder MW
Int J Med Microbiol; 2005 Jan; 294(7):437-45. PubMed ID: 15715172
[TBL] [Abstract][Full Text] [Related]
17. Nasal vaccination with attenuated Salmonella expressing VapA: TLR2 activation is not essential for protection against R. equi infection.
Cardoso SA; Oliveira AF; Ruas LP; Trevisani MM; De Oliveira LL; Hanna ES; Roque-Barreira MC; Soares SG
Vaccine; 2013 Sep; 31(41):4528-35. PubMed ID: 23933366
[TBL] [Abstract][Full Text] [Related]
18. Protective effect against Rhodococcus equi infection in mice of IgG purified from horses vaccinated with virulence associated protein (VapA)-enriched antigens.
Fernandez AS; Prescott JF; Nicholson VM
Vet Microbiol; 1997 Jun; 56(3-4):187-92. PubMed ID: 9226833
[TBL] [Abstract][Full Text] [Related]
19. Virulence plasmid of Rhodococcus equi contains inducible gene family encoding secreted proteins.
Byrne BA; Prescott JF; Palmer GH; Takai S; Nicholson VM; Alperin DC; Hines SA
Infect Immun; 2001 Feb; 69(2):650-6. PubMed ID: 11159951
[TBL] [Abstract][Full Text] [Related]
20. Antigenic analysis of Rhodococcus equi preparations using different horse sera.
Fontanals AM; Becú T; Polledo G; Gaskin CK; Braun M
Vet Microbiol; 1997 Jun; 56(3-4):247-55. PubMed ID: 9226839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
